Evidence map›Paper›PMID 41532473›Full record

ArticleFEBS open bio2026

Microglial dynamics and ferroptosis induction in human iPSC-derived neuron-astrocyte-microglia tri-cultures.

Hongmei Lisa Li, Hiroko Ohmiya, Sou Sakamoto, Masato Yugami, Akiko Oki, Makoto Furusawa, Yan Ling

Abstract read
In one paragraph

Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongmei Lisa LiNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.ORCID https://orcid.org/0009-0002-1228-8761
Hiroko OhmiyaNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.
Sou SakamotoNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.
Masato YugamiNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.
Akiko OkiNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.
Makoto FurusawaNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.
Yan LingNeuroscience Translational Medicine, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company, Fujisawa, Japan.

Funding

Takeda Pharmaceutical Company
6 · The paper itself

Abstract

The dynamics of microglial activity within neuron-astrocyte-microglia tri-cultures derived from human induced pluripotent stem cells (iPSCs) present a complex interplay and offer an opportunity to obtain new insights into neuron-glia interactions. Iron-laden microglia, correlating with functional changes, represent a key pathological feature of Alzheimer's disease (AD). This study characterized the cellular crosstalk and transcriptional states of microglia in tri-cultures. Complement C3 can be detected in culture media when microglia are cocultured with neurons, and the addition of astrocytes in the coculture led to an increased amount of C3, indicating that the impact of glial interactions can be evaluated in this model system. We compared microglial gene expression profiles comprehensively in monoculture, coculture, and tri-culture settings. Single-cell RNA sequencing (scRNA-seq) revealed various microglial states with gene expression changes associated with endocytosis and neuron-related functions in tri-culture settings, suggesting that microglial behavior is profoundly impacted by the presence of neurons and astrocytes. We assessed microglial responses to iron overload combined with the ferroptosis inducer RSL3 (a GPX4 inhibitor) in tri-cultures. Microglial cell death was accompanied by ferritin heavy-chain expression, indicating microglia ferroptosis. scRNA-seq analyses highlighted alterations in pathways related to ferroptosis, stress response, and autophagy, indicating substantial shifts in microglial profiles upon iron perturbation. These findings underscore the necessity of using tri-cultures as a model to capture certain degrees of complex cellular interactions occurring in vivo. These results offer critical insights for establishing in vitro models for therapeutic development of neurodegenerative diseases, including AD.

Indexed as

AstrocytesFerroptosisInduced Pluripotent Stem CellsMicrogliaNeuronsCells, CulturedCoculture TechniquesHumansferroptosisiPSC tri‐culturesingle‐cell RNA‐seqtranscriptomics

Identifiers

PMID41532473
PMCPMC13238601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.